Description: Gossamer Bio is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology. Its goal is to be an industry leader in each of these therapeutic areas and to enhance and extend the lives of patients suffering from such diseases.
Home Page: www.gossamerbio.com
GOSS Technical Analysis
3013 Science Park Road
San Diego,
CA
92121
United States
Phone:
858 684 1300
Officers
| Name | Title |
|---|---|
| Mr. Faheem Hasnain | Co-Founder, CEO, Pres & Chairman |
| Mr. Bryan Giraudo | COO & CFO |
| Mr. Christian Waage | Exec. VP of Technical Operations & Admin. |
| Dr. Laura L. Carter Ph.D. | Chief Scientific Officer |
| Mr. Jeff Boerneke | Gen. Counsel & Sec. |
| Ms. Deanna Weber | Sr. VP of HR |
| Dr. Richard Aranda M.D. | Chief Medical Officer |
| Mr. Mario Orlando | Sr. VP of Commercial New Product Planning |
| Ms. Caryn L. Peterson | Exec. VP of Regulatory Affairs |
| Mr. Matt Cravets | Sr. VP of Biometrics |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 4.0908 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2019-02-08 |
| Fiscal Year End: | December |
| Full Time Employees: | 185 |